TRI-MOXI PLUS Trademark

Trademark Overview

On Tuesday, December 28, 2021, a trademark application was filed for TRI-MOXI PLUS with the United States Patent and Trademark Office. The USPTO has given the TRI-MOXI PLUS trademark a serial number of 97193506. The federal status of this trademark filing is FOURTH EXTENSION - GRANTED as of Friday, May 10, 2024. This trademark is owned by Harrow IP, LLC. The TRI-MOXI PLUS trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical compositions for ocular or intraocular surgery
tri-moxi plus

General Information

Serial Number97193506
Word MarkTRI-MOXI PLUS
Filing DateTuesday, December 28, 2021
Status733 - FOURTH EXTENSION - GRANTED
Status DateFriday, May 10, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 5, 2022

Trademark Statements

Goods and ServicesPharmaceutical compositions for ocular or intraocular surgery

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, January 4, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameHarrow IP, LLC
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressNashville, TN 37205
Party NameHarrow IP, LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressNashville, TN 37205

Trademark Events

Event DateEvent Description
Tuesday, January 4, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, February 28, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, December 31, 2021NEW APPLICATION ENTERED
Monday, February 28, 2022ASSIGNED TO EXAMINER
Tuesday, April 5, 2022PUBLISHED FOR OPPOSITION
Wednesday, March 16, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, April 5, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Wednesday, November 30, 2022SOU TEAS EXTENSION RECEIVED
Wednesday, November 30, 2022SOU EXTENSION 1 FILED
Wednesday, November 30, 2022SOU EXTENSION 1 GRANTED
Tuesday, May 31, 2022NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Wednesday, April 12, 2023ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Friday, December 2, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, May 25, 2023SOU TEAS EXTENSION RECEIVED
Thursday, May 25, 2023SOU EXTENSION 2 FILED
Thursday, May 25, 2023SOU EXTENSION 2 GRANTED
Saturday, May 27, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Saturday, December 2, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, May 10, 2024SOU TEAS EXTENSION RECEIVED
Friday, May 10, 2024SOU EXTENSION 4 GRANTED
Friday, May 10, 2024SOU EXTENSION 4 FILED
Saturday, May 11, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, November 30, 2023SOU EXTENSION 3 GRANTED
Thursday, November 30, 2023SOU TEAS EXTENSION RECEIVED
Thursday, November 30, 2023SOU EXTENSION 3 FILED

Related Keywords

plus moxi surgery intraocular ocular compositions pharmaceutical